Who invested in Epitome Therapeutics?
Epitome Therapeutics's investors include XISTA Science Ventures, Caesar. and Navec Venture Holding GmbH. XISTA Science Ventures led its latest round.
Austria · Pre-seed startup
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 4 months ago
Funding summaryUpdated 26 Oct 2026
$4.6Mraised across 1 round since 2026, from 2 sources
Reported by Firms' own news pages and 1 other
Epitome Therapeutics's investors include XISTA Science Ventures, Caesar. and Navec Venture Holding GmbH. XISTA Science Ventures led its latest round.
Epitome Therapeutics has raised $4.6M across 1 round since 2026.
Epitome Therapeutics's most recent round was a Pre-seed of $4.6M in Jun 2026, led by XISTA Science Ventures.
Its most recent round, $4.6M in Jun 2026, is also its largest on record.
Epitome Therapeutics's first round on record, in Jun 2026, was backed by XISTA Science Ventures, Caesar. and Navec Venture Holding GmbH.
Epitome Therapeutics's latest named round is a Pre-seed, in Jun 2026.
Epitome Therapeutics is based in Austria.
XISTA Science Ventures led the Pre-seed in 2026.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.